$PMBS Headlines 10-K: PURAMED BIOSCIENCE INC. 4:
Post# of 144499
Posted On: 01/03/2014 2:05:57 PM
$PMBS Headlines
10-K: PURAMED BIOSCIENCE INC. 4:16 p.m. Oct. 15, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-Q: PURAMED BIOSCIENCE INC. 4:25 p.m. May 15, 2013 - Edgar Online - (EDG = 10Q, 10K)
3 Penny Stocks to Watch 11:41 p.m. May 14, 2013 - InvestorPlace.com
10-Q: PURAMED BIOSCIENCE INC. 4:13 p.m. Feb. 14, 2013 - Edgar Online - (EDG = 10Q, 10K)
PuraMed BioScience®, Inc., Launches LipiGesic M Sampling Campaign Targeting Headache Specialists 12:18 p.m. Sept. 25, 2013 - PR Newswire
PuraMed BioScience Invited to Discuss LipiGesic M on Armed Forces Network 11:03 a.m. Aug. 29, 2013 - PR Newswire
PuraMed BioScience Sponsors Miles for Migraine Race with LipiGesic M 7:00 a.m. Aug. 22, 2013 - PR Newswire
PuraMed BioScience Announces Distributor Agreement with OuterBanks Outdoors 1:08 p.m. Aug. 14, 2013 - PR Newswire
LipiGesic M is the only recommended first-line therapy for acute migraine that has no evidence of rebound headache 2:44 p.m. Aug. 5, 2013 - PR Newswire
PuraMed BioScience Announces Common Shares Outstanding of 42.6 Million 10:27 a.m. July 2, 2013 - PR Newswire
PuraMed BioScience? Announces Science Behind LipiGesic? M Migraine Treatment 10:05 a.m. June 21, 2013 - PR Newswire
PuraMed BioScience? Announces Interview on Big Biz Show Discussing LipiGesic? M 7:00 a.m. June 10, 2013 - PR Newswire
PuraMed BioScience Discusses Potential for Patent Portfolio Acquisition 10:11 a.m. May 30, 2013 - PR Newswire
PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 1:10 p.m. May 23, 2013 - PR Newswire
LipiGesic? M Migraine Treatment Product Shown to be as Effective as Prescription Based Medications 1:33 p.m. May 21, 2013 - PR Newswire
PuraMed BioScience?, Inc., Launches Its Business-to-Business Migraine First Aid Kit(TM) to Promote Workplace Health and Wellness 3:01 p.m. May 15, 2013 - PR Newswire
PuraMed BioScience? Expands International Distribution with Order from Colombia, South America 10:13 a.m. May 13, 2013 - PR Newswire
Ludlow Research Issues Opinion on PMBS Based on Low Market Cap Valuation 8:49 a.m. April 24, 2013 - PR Newswire
PuraMed BioScience® Inc., Announces Manufacturing and Packaging Vendors for LipiGesic® M, its Highly Effective, Non-Prescription Migraine Pain Reliever 7:00 a.m. April 18, 2013 - PR Newswire
PuraMed BioScience to Expand Marketing of Over-the-Counter Migraine Product to Additional National Retail Chains 11:34 a.m. April 12, 2013 - PR Newswire
Reanalysis of Clinical Trial Data Confirms LipiGesic? M has Robust Efficacy for Treatment of Migraine Headache and Associated Symptoms 1:58 p.m. March 5, 2013 - PR Newswire
PuraMed BioScience?Inc., Manufacturers of LipiGesic? M, Engaged FOCUS LLC, an Investment Banking Firm, to Explore Strategic Alternatives 3:09 p.m. Feb. 26, 2013 - PR Newswire
PuraMed BioScience? Receives Patent Allowance on Over-the-Counter Migraine Pain Reliever, LipiGesic?M 7:00 a.m. Jan. 15, 2013 - PR Newswire
10-K: PURAMED BIOSCIENCE INC. 4:16 p.m. Oct. 15, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-Q: PURAMED BIOSCIENCE INC. 4:25 p.m. May 15, 2013 - Edgar Online - (EDG = 10Q, 10K)
3 Penny Stocks to Watch 11:41 p.m. May 14, 2013 - InvestorPlace.com
10-Q: PURAMED BIOSCIENCE INC. 4:13 p.m. Feb. 14, 2013 - Edgar Online - (EDG = 10Q, 10K)
PuraMed BioScience®, Inc., Launches LipiGesic M Sampling Campaign Targeting Headache Specialists 12:18 p.m. Sept. 25, 2013 - PR Newswire
PuraMed BioScience Invited to Discuss LipiGesic M on Armed Forces Network 11:03 a.m. Aug. 29, 2013 - PR Newswire
PuraMed BioScience Sponsors Miles for Migraine Race with LipiGesic M 7:00 a.m. Aug. 22, 2013 - PR Newswire
PuraMed BioScience Announces Distributor Agreement with OuterBanks Outdoors 1:08 p.m. Aug. 14, 2013 - PR Newswire
LipiGesic M is the only recommended first-line therapy for acute migraine that has no evidence of rebound headache 2:44 p.m. Aug. 5, 2013 - PR Newswire
PuraMed BioScience Announces Common Shares Outstanding of 42.6 Million 10:27 a.m. July 2, 2013 - PR Newswire
PuraMed BioScience? Announces Science Behind LipiGesic? M Migraine Treatment 10:05 a.m. June 21, 2013 - PR Newswire
PuraMed BioScience? Announces Interview on Big Biz Show Discussing LipiGesic? M 7:00 a.m. June 10, 2013 - PR Newswire
PuraMed BioScience Discusses Potential for Patent Portfolio Acquisition 10:11 a.m. May 30, 2013 - PR Newswire
PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 1:10 p.m. May 23, 2013 - PR Newswire
LipiGesic? M Migraine Treatment Product Shown to be as Effective as Prescription Based Medications 1:33 p.m. May 21, 2013 - PR Newswire
PuraMed BioScience?, Inc., Launches Its Business-to-Business Migraine First Aid Kit(TM) to Promote Workplace Health and Wellness 3:01 p.m. May 15, 2013 - PR Newswire
PuraMed BioScience? Expands International Distribution with Order from Colombia, South America 10:13 a.m. May 13, 2013 - PR Newswire
Ludlow Research Issues Opinion on PMBS Based on Low Market Cap Valuation 8:49 a.m. April 24, 2013 - PR Newswire
PuraMed BioScience® Inc., Announces Manufacturing and Packaging Vendors for LipiGesic® M, its Highly Effective, Non-Prescription Migraine Pain Reliever 7:00 a.m. April 18, 2013 - PR Newswire
PuraMed BioScience to Expand Marketing of Over-the-Counter Migraine Product to Additional National Retail Chains 11:34 a.m. April 12, 2013 - PR Newswire
Reanalysis of Clinical Trial Data Confirms LipiGesic? M has Robust Efficacy for Treatment of Migraine Headache and Associated Symptoms 1:58 p.m. March 5, 2013 - PR Newswire
PuraMed BioScience?Inc., Manufacturers of LipiGesic? M, Engaged FOCUS LLC, an Investment Banking Firm, to Explore Strategic Alternatives 3:09 p.m. Feb. 26, 2013 - PR Newswire
PuraMed BioScience? Receives Patent Allowance on Over-the-Counter Migraine Pain Reliever, LipiGesic?M 7:00 a.m. Jan. 15, 2013 - PR Newswire
(0)
(0)Scroll down for more posts ▼